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Abstract: 
Although levels of triglycerides have consistently shown a strong association with cardiovascular disease In 
both case-control and cohort studies, it remains controversial whether this relation exists Independently of 
levels of cholesterol and other risk factors. The association of arteriographically documented coronary artery 
disease with plasma levels of triglycerides, total cholesterol, and high density lipoprotein (HDL) cholesterol was 
therefore examined in 5,216 white adults (81% were male) referred to two Milwaukee hospitals between 1972 
and 1988. Elevated levels of triglycerides were related to the extent of coronary artery disease (estimated using 
the total number and severity of stenoses). In both sexes, this association existed independently of total 
cholesterol, age, obesity, hypertension, smoking, and alcohol consumption. In addition, the association between 
triglycerides and coronary artery occlusion was strongest at total cholesterol levels ≤250 mg/dl. However, both 
+stratified and regression analyses Indicated there was no residual association between triglyceride levels and 
occlusion after controlling for HDL cholesterol. (Levels of HDL cholesterol and triglycerides showed a 
moderate Inverse association: r = -0.39 to -0.51.) These results indicate that the association between coronary 
artery occlusion and levels of triglycerides is indirect, and that the disparate findings of earner studies may have 
resulted from not controlling for HDL cholesterol. 
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Article: 
Much evidence supports an association between elevated levels of triglycerides and coronary heart disease. 
Diseases associated with high triglyceride levels (e.g., diabetes mellitus, obesity, chronic renal disease, and 
certain primary hyperlipoproteinemias) carry an increased risk of cardiovascular disease (1-3). Persons with 
angiographically-documented coronary artery disease (4-7) and survivors of myocardial infarctions (8-10) have 
consistently been found to have elevated levels of triglycerides. In addition, several prospective studies have 
found levels of triglycerides to be predictive of cardiovascular disease in at least some race-sex groups (11-18), 
and an experimental model for the possible atherogenic effects of hypertriglyceridemia has been postulated 
(19). Persons with mild hypertriglyceridemia (250-500 mg/dl) have approximately a twofold increased risk for 
cardiovascular disease (2). 
 
Nevertheless, the independent relation of triglyceride levels to coronary heart disease remains controversial 
(20). Levels of triglycerides and high density lipoprotein (HDL) cholesterol are inversely related (with reported 
correlation coefficients ranging from -0.21 to -0.65 (21)), and low levels of HDL cholesterol have been related 
to cardiovascular disease in both clinical (22, 23) and prospective (24, 25) studies. The relation between 
triglyceride levels and cardiovascular disease may therefore be indirect, and has been eliminated by control-ling 
for HDL cholesterol (20, 24). 
 
However, the inherent problems in controlling for closely related variables in regression analysis have been 
emphasized (26, 27), and recent analyses suggest that levels of triglycerides may be an independent risk factor 
for coronary heart disease in men with HDL cholesterol levels below 40 mg/dl and in women (28). Results from 
the Paris Prospective Study also suggest an interaction between levels of cholesterol and triglycerides in men: 
triglycerides may be predictive of coronary heart disease only at low (<220 mg/dl) serum levels of cholesterol 
(18). 
 
However, possible interactions between levels of triglycerides, total cholesterol, and HDL cholesterol with 
angiographically-documented coronary artery disease have not been examined. The objective of the current 
study, therefore, is to examine these interrelations (using both stratification and regression analyses) in a clinical 
database containing over 5,000 white adults. 
 
MATERIALS AND METHODS 
Population and disease status 
Established in 1972, the Milwaukee Cardiovascular Data Registry is a clinical database consisting of patients 
referred to selected Milwaukee hospitals (St. Luke's and Wood Veterans Administration Hospital) for 
diagnostic coronary angiography. Indications for coronary angiography include 1) unstable angina pectoris, 2) 
moderate to severe stable angina, 3) previous myocardial infarction, and 4) recurrent chest pain of unknown 
origin. Current analyses are restricted to whites who underwent arteriography between 1972 and 1986; other 
groups (including blacks, Asians, American Indians, and Hispanics) represented less than 5 per cent (n = 312) 
of all patients. An additional 357 patients are excluded because either age (at time of catheterization) or race 
was not recorded Plasma levels of both total cholesterol and triglycerides were available for 7,529 patients. 
The extent of atherosclerotic disease in the main coronary arteries and branches was evaluated, without 
knowledge of risk factor data, by a radiologist and cardiologist experienced in the interpretation of arteriograms. 
Disagreements were resolved by consensus after consultation with a second cardiologist. Although possible 
variability in these readings was not assessed, others (29, 30) have reported a moderate degree of intra- and 
interobserver reproducibility. 
 
Results were recorded according to a procedure suggested by Rowe et al. (31); however, the scale was inverted. 
The severity (per cent reduction in lumen diamet.er) of each occlusion in the three principal coronary arteries 
(right, left anterior descending, and left circumflex) was estimated. An (overall) occlusion score of 0 reflects no 
observed occlusion of any artery, while a maximum score of 300 represents total occlusion of the major vessels. 
Because the left main coronary artery supplies both the circumflex and anterior descending arteries, occlusions 
in this artery were doubled (e.g., a 50 per cent reduction received a score of 100). The number of diseased (>75 
per cent reductions in lumen diameter) vessels was also recorded. 
 
Risk factor information 
Medical records and questionnaires were used to obtain data concerning demographics, weight, height, alcohol 
consumption, smoking history, history of hypertension, previous myocardial infarction, angina, diabetes 
mellitus, and medication use. Persons were excluded from the current analyses if they reported use of thyroid or 
cholesterol-lowering medication, use of oral contraceptives or sex hormones, a history of diabetes mellitus, or 
hypo- or hyperthyroidism. These restrictions eliminated 1,649 persons; diabetics (n = 669) and persons using 
cholesterol-lowering drugs (n = 495) represented the majority of exclusions. 
 
For the remaining 5,216 persons, height and weight were used to calculate Quetelet index (kg/m
2
) (32). A five-
point smoking scale, reflecting both frequency and duration of smoking (1: never smoked, 5: smoked two or 
more packs daily for 20 years or 1.5 packs daily for 30 years) was calculated as previously described (33). 
Alcohol intake (including beer, wine, and mixed drinks) was converted to ounces of absolute alcohol per week. 
Complete information on all covariates was available for 4,432 (85 per cent) persons. 
 
Following an overnight fast, blood samples were collected before angiography. Plasma levels of total 
cholesterol and triglycerides were measured using automated procedures (34-36) in a laboratory that has been 
standardized by the Centers for Disease Control and is monitored by its surveillance program. Beginning in 
1977, HDL cholesterol was measured using procedures employed by the Lipid Research Clinics (36); these 
levels were available for 1,123 persons. 
 
Mild hypertriglyceridemia (250-500 mg/ dl) was present in 17 per cent of all males and 10 per cent of females; 
plasma triglyceride levels above 500 mg/dl were observed in 2 per cent of males and 1 per cent of females. Of 
persons with plume cholesterol levels below 250 mg/dl, mild hypertriglyceridemia was present in 12 per cent of 
males and 6 per cent of females. 
 
Statistical analyses 
Bivariate associations among coronary artery occlusion and various risk factors were assessed using Spearman 
correlations, and although several variables were not normally distributed, Pearson correlations yielded similar 
results. (Because of the numerous correlations examined and the large sample size, p values <0.001 were 
considered to be statistically significant in these analyses.) To examine the independent effects of triglycerides 
and cholesterol, mean occlusion scores were first calculated following a cross-classification of these two lipids. 
(Categories were chosen to yield roughly equivalent numbers of persons in each stratum.) Analysis of 
covariance was then used to examine main effects and possible interactions after controlling for age, Quetelet 
index, alcohol consumption, smoking history, and hypertension. 
 
The interaction between plasma cholesterol and triglyceride levels was further examined in a series of 
regression models. A cholesterol level of 250 mg/dl was first used to dichotomize plasma cholesterol in the 
interaction term (0: ≤250 mg/dl; 1: >250 mg/dl). In addition, separate regression analyses were performed 
within the two cholesterol strata. Assumptions concerning normality and homoscedasticity (constant error 
variance) of residuals were verified in all regression analyses. 
 
The independence of HDL cholesterol levels and triglycerides was further examined in persons with plasma 
total cholesterol levels ≤250 mg/dl. A series of multiple regression equations was again calculated, and the 
tolerance (37) of each regression coefficient was calculated. Tolerance is defined as 1 — R
2
 for a variable 
regressed on all other independent variables, and indicates the amount of variability that is "unexplained" by the 
other independent variables. (A low tolerance means that the independent variable is almost a linear 
combination of other independent variables.) Mean occlusion scores were also calculated after a cross-
classification of plasma levels of total cholesterol, cholesterol, and triglycerides. 
 
Persons with extreme occlusion scores (0 or >200) were used in an additional graphic analysis. After adjusting 
occlusion for the effects of other risk factors, disease status (low or high occlusion scores) was plotted against 
levels of triglycerides and HDL cholesterol. Mean values of these two plasma lipids were used to divide the 
data into four areas. The odds (38) of severe:minimal disease within each quadrant are shown, and odds ratios 
for severe disease were calculated. 
 
RESULTS 
Table 1 shows mean values of selected characteristics. The maximum coronary artery occlusion score was 295 
in males and 285 in females, with approximately 18 per cent (n = 771) of males and 47 per cent (n = 455) of 
females having no observable occlusion. Although age and cholesterol levels showed no difference between the 
sexes, males had higher plasma levels (+38 mg/dl) of triglycerides and lower levels (-9 mg/dl) of HDL 
cholesterol. In addition, males tended to consume more alcohol and were heavier (past) smokers than were 
females. Male-female differences in the extent of occlusion were reduced by controlling for age, total and HDL 
cholesterol, triglycerides, Quetelet index, alcohol consumption, smoking history, and hypertension, but a higher 
occlusion score was still evident in males (122 vs. 89). 
 
Spearman correlation coefficients are shown in table 2. Associations between risk factors and the occlusion 
score were generally stronger in females, although the ratio of total to HDL cholesterol showed the highest 
correlation with the extent of occlusion in both sexes. Levels of plasma cholesterol and triglycerides showed 
similar associations with occlusion (r = 0.16 and 0.14 in males, r = 0.32 and 0.30 in females). In addition, levels 
of triglycerides were correlated positively with total cholesterol (r = 0.38 to 0.39) and inversely with HDL 
cholesterol (r = -0.39 to -0.51). In general, Quetelet index, hypertension, smoking history, and alcohol 
consumption were associated with levels of both triglycerides and HDL cholesterol. 
 
Associations between triglyceride levels and coronary artery occlusion were then examined within strata of 
other variables. Occlusion was more strongly related to plasma triglyceride levels in persons with-out a previous 
myocardial infarction than in those who reported a myocardial infarction (r = 0.18 vs. 0.07, males; r = 0.28 vs. 
0.22, females). Although a stronger association between triglyceride levels and occlusion was also seen in males 
who did not use 0-blockers (r = 0.17 vs. 0.05), a comparable trend was not seen in females (r = 0.25 vs. 0.33). 
No differences in the magnitudes of the associations were seen across strata of smoking, alcohol consumption, 
and use of diuretics or antihypertensive agents. 
 
Table 3 shows mean (unadjusted) occlusion scores after levels of total cholesterol and triglycerides were cross-
classified. Main effects of both lipids were statistically significant (p < 0.01) in all four sex-age groups. 
However, negative interactions between levels of cholesterol and triglycerides were also observed. For example, 
in older males with plasma cholesterol levels ≤210 mg/dl, the mean occlusion score increased by 27 (from 116 
to 143) as plasma triglyceride levels increased. However, at plasma cholesterol levels >250 mg/dl, the 
association between levels of triglycerides and occlusion was inconsistent. In addition, among young females 
who had plasma triglyceride levels >195 mg/dl, the highest mean occlusion score was seen at low levels of total 
cholesterol. 
 
Various combinations of total cholesterol and triglycerides were then used in regression models to predict the 
extent of occlusion (table 4). Even after adjusting for the nonlipid risk factors, plasma levels of both cholesterol 
and triglycerides were significant predictors of coronary artery disease (modeb3 1 and 2). Furthermore, each 
lipid component was independently related to occlusion (model 3); the regression coefficient for triglycerides, 
however, was reduced after controlling for total cholesterol. (In model 3, standardized regression coefficients 
for males were 0.15 (cholesterol) and 0.06 (triglycerides); for females, 0.24 and 0.08.) The interaction between 
cholesterol and triglycerides was then assessed in model 4, and in males the association between triglyceride 
levels and occlusion was strongest at cholesterol levels ≤250 mg/dl. Although the negative, dichotomous inter-
action was not statistically significant in females (p =  0.36), a continuous interaction term (formed by 
multiplying levels of the two lipids together) approached statistical significance (p = 0.07, data not shown). 
 
Regression analyses, stratifying by sex and total cholesterol, confirmed that a negative interaction existed 
between total cholesterol and triglycerides. At low levels (≤250 mg/dl) of total cholesterol, regression 
coefficients for triglycerides were 0.08 (males) and 0.16 (females); p < 0.001 for both values. In contrast, at 
total cholesterol levels >250 mg/dl, the corresponding regression coefficients for triglycerides were 0.03 (males) 
and 0.01 (females). 
 
To assess the independent relations of triglycerides and HDL cholesterol levels with coronary artery disease, an 
analogous set of analyses were then performed in normocholesterolemic persons (plasma total cholesterol ≤250 
mg/dl) who had HDL cholesterol measurements (table 5). In these persons, levels of triglycerides and total 
cholesterol were each independently related to occlusion in males, whereas (possibly because of the smaller 
sample size) only triglycerides were a significant predictor of occlusion in females. However, triglyceride levels 
were no longer related to occlusion in either sex after controlling for HDL cholesterol (model 4). 
 
 
 
Mean occlusion scores (adjusted for total cholesterol and nonlipid risk factors) are shown for ea.ch sex in table 
6, according to plasma levels of triglycerides, total cholesterol, and HDL cholesterol. Although several of the 
cell sizes were small, coronary artery occlusion was inversely related to HDL cholesterol in nine of the 10 
possible comparisons. (The one exception was ob-served in males with low levels of total cholesterol, but high 
levels of triglycerides.) In contrast, the association between levels of triglycerides and occlusion was less 
consistent; no association was seen in males who had low levels of total and HDL cholesterol, or in females 
with high levels of total cholesterol. The five females with high total cholesterol levels, but low levels of both 
HDL cholesterol and triglycerides, all had occlusion scores above 171, emphasizing the relative importance of 
HDL cholesterol. 
 
Persons with either severe (>90
th
 percentile, males; >80
th
 percentile, females) or minimal (<10
th
 percentile, 
males; <20
th
 percentile, females) coronary artery disease were then included in an additional analysis. These 
extreme occlusion scores were first adjusted for total cholesterol and other risk factors, and then plotted 
according to plasma levels of both HDL cholesterol and triglycerides (figure 1). (This analysis would not reveal 
possible interactions with total cholesterol.) Mean levels of triglycerides and HDL cholesterol were used to 
divide the figure into four areas, and the odds of severe:minimal disease are shown for persons in each quadrant. 
 
 
As compared with triglycerides, levels of HDL cholesterol showed a stronger association with disease status. 
For example, in males with low plasma triglyceride levels, the odds of severe disease in persons with low (≤38 
mg/dl) levels of HDL cholesterol was 3.3 (1.47/0.44) times the odds in persons with high levels of HDL 
cholesterol. (A similar odds ratio, 3.4 (2.70/0.80), was seen between low levels of HDL cholesterol and severe 
disease in males with high triglyceride levels.) In contrast, high (vs. low) triglyceride levels were associated 
with an odds ratio of 1.8. Females showed similar associations between low HDL cholesterol and severe disease 
(odds ratios of 2.7 and 4.4), whereas odds ratios between triglyceride levels and occlusion were 1.6 and 1.0. 
 
 
 
DISCUSSION 
Despite the possibility of various biases in studies of persons undergoing arteriography, associations between 
risk factors and anatomically documented coronary artery disease have generally confirmed associations seen in 
prospective studies (39). The current results indicate that although the relation of triglycerides with coronary 
artery disease exists independently of serum total cholesterol in normocholesterolemic persons, there is little 
residual association after controlling for HDL cholesterol. Although levels of HDL cholesterol and triglycerides 
are inversely correlated, the extent of coronary artery occlusion is primarily related to decreased levels of HDL 
cholesterol, rather than to increased triglycerides. 
 
Bivariate associations between levels of triglycerides and cardiovascular disease have been reported 'in 
numerous prospective and retrospective studies (4-18), and even after controlling for total (or low-density 
lipoprotein) cholesterol, associations have persisted in some (5, 8, 12, 13, 16-18), but not all studies. However, 
the relation of triglycerides to cardiovascular disease may vary according to the clinical endpoint (myocardial 
infarction, cerebral stroke, or cardiovascular mortality) studied (12, 13, 16, 16), and it is also possible that 
triglyceride levels are predictive of coronary heart disease in women but not in men (11, 14). 
 
Based on results of the Paris Prospective Study, Cambien et al. (18) suggested that these different findings may 
be partly due to a stronger association of triglycerides with cardiovascular disease at low (vs. high) levels of 
total cholesterol. Results of the current analyses, along with studies of myocardial infarction survivors (9, 10), 
an autopsy study of adolescents (40), and a recent report from the Lipid Research Clinics (41) also emphasize 
the importance of triglycerides at low levels of total cholesterol. However, a recent prospective study of 
normocholesterolemic men (42) found that mild hypertriglyceridemia was not predictive of cardiovascular 
disease mortality. (Hypertriglyceridemia was approximately three times more prevalent in the current study.) 
The use of different clinical end-points may also contribute to the disparate results. The relation of cholesterol 
to sudden cardiac death may be weaker than its association with myocardial infarction (43), and analogous 
differences may exist for triglycerides. Therefore, the atherogenic effects of triglycerides may be best assessed 
using angiographically defined coronary artery disease as an endpoint. 
 
Hulley et al. (20) have suggested that controlling for levels of HDL cholesterol might eliminate any residual 
association between triglyceride levels and cardiovascular disease, and the current results support this 
hypothesis. However, the problems in controlling for a closely related variable in regression have been 
emphasized (26, 27), and alternative methods have been suggested. Abbott and Carroll (26) have proposed that 
the relation between a predictor (triglycerides) and dependent variable might be more accurately represented by 
its projected slope, which controls for only the nonredundant information in the covariate (HDL cholesterol).  
However, only a moderate correlation exists between levels of triglycerides and HDL cholesterol, with over 65 
per cent of the variability in plasma triglyceride levels unexplained by HDL cholesterol and other variables in 
the current study. Furthermore, after controlling for HDL cholesterol by stratification in the current study, 
triglycerides showed little residual association with occlusion, similar to results of the Cooperative Lipoprotein 
Phenotyping Study (8). 
 
Several methodological questions arise in angiographic studies of coronary artery disease. Because deaths 
(either sudden or due to myocardial infarction) occur, enrolled cases may not be representative of all per-sons 
with coronary artery disease, and the resulting distributioru3 of lipids and coronary artery disease may be 
attenuated. In addition, since elevated levels of cholesterol or triglycerides may influence the decision to 
perform diagnostic angiography, persons presenting with angina pectoris but without coronary artery disease 
may have elevated lipid levels. 
 
The inherent limitations of arteriograms in assessing atherosclerotic lesions should also be considered. 
Variability exists in their interpretation, with interobserver agreement reported to be as low as 63 per cent for 
lesions in the left anterior descending artery (29, 30). In addition, as compared with histologic findings, 
angiography tends to systematically underestimate the amount of disease (44). However, possible selection and 
misclassification biases in the current study would have resulted in a similar underestimation of the actual 
relation of coronary artery disease to levels of both triglycerides and HDL cholesterol. It is interesting that the 
association between triglycerides and occlusion was strongest in persons without a previous myocardial 
infarction; the occurrence of clinical disease may have led to lifestyle changes which altered triglyceride levels. 
 
Nevertheless, many of the observed associations correspond closely to those observed in population-based 
studies, arguing against marked biases. Male-female differences in levels of plasma triglycerides and HDL 
cholesterol, and interrelations among plasma levels of triglycerides, total cholesterol, and HDL cholesterol were 
com-parable to associations seen in more representative samples (45, 46). Positive associations of triglyceride 
levels with both Quetelet index and cigarette smoking were observed, and HDL cholesterol was associated with 
both Quetelet index (negatively) and alcohol consumption (positively). Data from the Framingham Study (47) 
also suggest that levels of triglycerides and HDL cholesterol may be more predictive of subsequent coronary 
heart disease in women than in men. The stronger cross-sectional associations observed with coronary artery 
occlusion among women in the current study were not due to the large proportion of females with occlusion 
scores of 0; analyses excluding nondiseased subjects yielded comparable male-female differences (data not 
shown). 
 
Even if not directly related to cardiovascular disease, it has been suggested that elevated levels of triglycerides 
may be a marker for certain forms of hyperlipoproteinemias (2). Although hypertriglyceridemics typically have 
decreased levels of HDL cholesterol, this association is not strong enough to be clinically useful (48). In 
addition, apolipoprotein A-I, which may be a better predictor of cardiovascular disease than is HDL cholesterol, 
is only weakly associated with triglycerides (49), and hypertriglyceridemics with normal levels of 
apolipoprotein B have minimal coronary artery disease (50). Because the prevalence of hypertriglyceridemia in 
normocholesterolemic persons is likely to be less than 5 per cent (42), measurement of triglyceride levels in the 
general population may yield little additional information concerning cardiovascular disease risk. 
 
The relative importance of levels of HDL cholesterol (vs. triglycerides) is also in agreement with most of the 
experimental evidence concerning atherosclerosis. Although Zilversmit (19) has suggested that the formation of 
chylomicron remnants may be atherogenic, triglycerides exhibit little sclerogenic activity (51) and cholesterol-
rich lipoprotein particles are more likely to penetrate the arterial wall (62). In contrast, many studies implicate 
HDL cholesterol in atherosclerosis (53), possibly by facilitating the efflux of intracellular cholesterol (54). 
Disparate findings of earlier epidemiologic studies concerning triglyceride levels are likely to have resulted 
from a failure to control for levels of HDL cholesterol. 
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